Old Second National Bank Of Aurora Abb Vie Inc. Transaction History

Old Second National Bank Of Aurora

$400 Million
Q3 2024

A detailed history of Old Second National Bank Of Aurora transactions in Abb Vie Inc. stock. As of the latest transaction made, Old Second National Bank Of Aurora holds 22,284 shares of ABBV stock, worth $3.68 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

22,284

Previous 22,945 2.88%

Holding current value

$3.68 Million

Previous $3.94 Million 11.82%

% of portfolio

1.1%

Previous 1.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $108,298 - $131,757	-661 Reduced 2.88%	22,284 $4.4 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $170,114 - $198,655	-1,099 Reduced 4.57%	22,945 $3.94 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $206,007 - $234,726	-1,289 Reduced 5.09%	24,044 $4.38 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $53,939 - $60,748	-392 Reduced 1.52%	25,333 $3.93 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $97,921 - $113,358	-733 Reduced 2.77%	25,725 $3.83 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $53,931 - $67,114	-407 Reduced 1.51%	26,458 $3.56 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $131,450 - $151,384	-909 Reduced 3.27%	26,865 $4.28 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $162,099 - $194,399	-1,172 Reduced 4.05%	27,774 $4.49 Million
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $207,622 - $238,129	-1,547 Reduced 5.07%	28,946 $3.89 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $213,035 - $270,838	-1,548 Reduced 4.83%	30,493 $4.67 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $184,640 - $229,086	-1,399 Reduced 4.18%	32,041 $5.19 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $11,065 - $14,000	103 Added 0.31%	33,440 $3.43 Million
Q3 2021 Dec 06, 2021	BUY	$106.4 - $120.78 $29,153 - $33,093	274 Added 0.83%	33,337 $3.6 Million
Q2 2021 Aug 30, 2021	SELL	$105.21 - $117.21 $101,212 - $112,756	-962 Reduced 2.83%	33,063 $3.73 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $47,774 - $52,593	467 Added 1.39%	34,025 $3.68 Million
Q4 2020 Feb 01, 2021	SELL	$80.49 - $108.67 $10,061 - $13,583	-125 Reduced 0.37%	33,558 $3.6 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $125,600 - $147,413	-1,462 Reduced 4.16%	33,683 $2.95 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $170,658 - $228,366	-2,326 Reduced 6.21%	35,145 $3.45 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $496,069 - $752,102	7,691 Added 25.83%	37,471 $2.86 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $44,936 - $56,225	623 Added 2.14%	29,780 $2.64 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $54,036 - $64,967	-858 Reduced 2.86%	29,157 $2.21 Million
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $6,175 - $7,894	-94 Reduced 0.31%	30,015 $2.18 Million
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $462,762 - $544,649	5,999 Added 24.88%	30,109 $2.43 Million
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $71,310 - $87,945	916 Added 3.95%	24,110 $2.22 Million
Q3 2018 Oct 24, 2018	BUY	$88.91 - $98.84 $83,130 - $92,415	935 Added 4.2%	23,194 $2.19 Million
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $727,487 - $860,781	8,103 Added 57.24%	22,259 $2.06 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $59,070 - $79,100	-642 Reduced 4.34%	14,156 $1.34 Million
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $28,659 - $31,427	-320 Reduced 2.12%	14,798 $1.43 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $1.06 Million - $1.35 Million	15,118	15,118 $1.34 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Second National Bank Of Aurora, based on Form 13F filings with the SEC.

News

Stay updated on Old Second National Bank Of Aurora with notifications on news.

Account

Old Second National Bank Of Aurora Abb Vie Inc. Transaction History